ANDA 204404, held by Pharmobedient. Methocarbamol.
As of Nov 14, 2026, ANDA 204404 (Methocarbamol), held by Pharmobedient, was first approved by FDA on Dec 5, 2014, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 5, 2014 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methocarbamol1GM/10ML (100MG/ML) ยท solution;im-iv | Methocarbamol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
